Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Hagerman Philip R	2. Issuer Name and Ticker or Trading Symbol Diplomat Pharmacy, Inc. [ DPLO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    __X__ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) 4100 S. SAGINAW STREET	3. Date of Earliest Transaction (MM/DD/YYYY) 10/2/2019
(Street) FLINT, MI 48507 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/2/2019		S(1)		2610 (1)	D	$4.8002 (2)	35871	D
Common Stock								1280099	I	Philip R. Hagerman Revocable Trust (3)
Common Stock								3391609	I	2007 Hagerman Family GST (4)
Common Stock								3600091	I	The JH GST Trust (3)
Common Stock								1475876	I	2013 Irrev. Exempt Trust for Daughter (4)
Common Stock								1475876	I	2013 Irrev. Exempt Trust for Son (4)
Common Stock								1075293	I	2013 Irrev. Exempt Trust for Daughter (3)
Common Stock								1311292	I	2013 Irrev. Exempt Trust for Daughter (3)
Common Stock								313337	I	2014 Irrev. Exempt Trust for Son (4)
Common Stock								313337	I	2014 Irrev. Exempt Trust for Daughter (4)
Common Stock								313337	I	2014 Irrev. Exempt Trust for Daughter (3)
Common Stock								313337	I	2014 Irrev. Exempt Trust for Daughter (3)
Common Stock								367528	I	Jocelyn Hagerman Living Trust (4)
Common Stock								263500	I	JH Marital Trust (3)
Common Stock								272000	I	PH Marital Trust (4)
Common Stock								394910	I	Irrevocable Trust for Son
Common Stock								394910	I	Irrevocable Trust for Daughter
Common Stock								367256	I	Irrevocable Non-Exempt Trust for Son
Common Stock								367256	I	Irrevocable Non-Exempt Trust for Daughter

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:
(1)	The sales reported in this Form 4 represent shares sold automatically to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
(2)	The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $4.72 to $4.85. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
(3)	These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.
(4)	Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her as a trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, the Jocelyn Hagerman Living Trust, and the PH Marital Trust.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Hagerman Philip R 4100 S. SAGINAW STREET FLINT, MI 48507	X	X

Signatures
/s/ Christina Flint, by Power of Attorney		10/4/2019
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Diplomat Pharmacy Chart

1 Month Diplomat Pharmacy Chart